摘要
目的 探讨中药在治疗白内障术后糖尿病性黄斑水肿的效果。方法 分析2020年1月至2021年7月余姚市人民医院住院行白内障超声乳化吸除术后糖尿病性黄斑水肿患者38例（65眼）的临床资料，按照区组随机分为两组，中药治疗为实验组，羟苯磺酸钙治疗为对照组。观察两组治疗前和治疗后4、8、12周的眼底病变情况、最佳矫正视力、黄斑中心厚度。结果 实验组与对照组治疗后8周及12周黄斑中心厚度降低，差异具有统计学意义（P<0.05）。治疗后8周，实验组黄斑中心厚度低于对照组，差异具有统计学意义（P<0.05）。结论 在白内障术后糖尿病性黄斑水肿患者中，内服中药治疗，可使患者黄斑水肿减轻，延缓疾病的进展。
关键词： 中药；白内障术；糖尿病；黄斑水肿
Abstract
Objective To explore the effect of traditional Chinese medicine in the treatment of diabetic macular edema after cataract surgery. Methods The clinical data of 38 patients (65 eyes) with diabetic macular edema after cataract phacoemulsification were analyzed in Yuyao People's Hospital from January 2020 to July 2021, and they were randomly divided into two groups according to the group. The experimental group was treated with traditional Chinese medicine and the control group was treated with calcium isobenesulfonate. The fundus lesions, the best corrected visual acuity and the central thickness of macula were observed before treatment and 4, 8 and 12 weeks after treatment. Results The central macular thickness of the experimental group and the control group decreased at 8 weeks and 12 weeks after treatment, and the difference was statistically significant (P<0.05). After 8 weeks of treatment, the central macular thickness of the experimental group was lower than that of the control group, and the difference was statistically significant (P<0.05). Conclusion In patients with diabetic macular edema after cataract surgery, taking Chinese medicine can reduce macular edema and delay the progression of the disease.
Key words： Traditional Chinese medicine; Cataract surgery; Diabetes mellitus; Macular edema
参考文献 References
[1] 赵洋,石岩. 糖尿病黄斑水肿发病机制和治疗进展[J]. 医学综述.2019,(17):3463-3472.
[2] Rangasamy S, McGuire PG, Das A. Diabetic Retinopathy and Inflammation: Novel Therapeutic Targets[J]. Middle East Afr J Ophthalmol,2012,19(1):52-59.
[3] Antonetti DA, Klein R, Gardner TW. Diabetic retinopathy[J]. N Engl J Med,2012,336(13):1227-1239.
[4] 付文革. 七叶皂苷钠治疗糖尿病视网膜病变视乳头水肿的疗效观察[J]. 海峡药学,2014,11:179-180.
[5] 杨金奎,鹿斌. 糖尿病视网膜病变防治专家共识[J]. 中华糖尿病杂志,2018,04:241-247.
[6] 王宁. 上海北新泾街道社区糖尿病视网膜病变患者黄斑水肿发病情况调查[A]. 中华医学会.第三届全球华人眼科学术大会暨中华医学会第十一届全国眼科学术大会论文汇编[C].中华医学会:,2006:1.
[7] 安娟,红华. 糖尿病黄斑水肿的诊断进展[J]. 内蒙古医学杂志,2019,01:41-43.
[8] 英瑛,丁慰祖. 糖尿病性黄斑水肿的光学相干断层扫描图像特征[J]. 临床和实验医学杂志,2017,15:1551-1553.
[9] 赵子君,柯晓云. 糖尿病性黄斑水肿治疗方式的研究进展[J]. 眼科新进展,2019,06:596-600.
[10] 陶雪. 三种抗VEGF药治疗糖尿病性黄斑水肿的有效性和安全性评价[D].电子科技大学,2022.
[11] 孙瑞雪,唐广贤,邸平会. 糖尿病性黄斑水肿激光治疗前后视网膜功能的定量研究[J]. 国际眼科杂志,2017,03:550-552.
[12] 郭向阳,黄洲基,朱志刚. 羟苯磺酸钙治疗糖尿病视网膜黄斑水肿观察[J]. 医药论坛杂志,2007,16:67-69.
[13] 赵娜,关微,刘德成. 羟苯磺酸钙联合阿柏西普治疗糖尿病性黄斑水肿的效果[J]. 中华眼外伤职业眼病杂志.2021, (12): 950-955.